Wednesday, August 4, 2010

Visudyne therapy

Age-related macular degeneration (AMD) is a progressive disease of the eye, meaning that it can’t be cured. The good news is that AMD can be controlled. Treatments available today can slow the vision loss associated with AMD and even restore some vision.

Wet and dry age-related macular degeneration (AMD) differ in several important respects, including treatment options. The only way to find out which AMD treatment regimen or management plan is right for you is to talk to your ophthalmologist or retinal specialist.

Visudyne therapy treats a form of AMD called predominantly classic subfoveal CNV due to AMD.

In this form of AMD, abnormal blood vessels leak fluid and/or blood under the macula—the part of the eye responsible for central vision—causing serious vision loss. During therapy, Visudyne is injected into the patient (generally through the arm). Next, light from a low-energy laser activates Visudyne, causing it to destroy the leaky vessels. As a part of a wet AMD treatment regimen, Visudyne therapy may help slow its progression.

Ask your ophthalmologist or retinal specialist if Visudyne therapy may be right for you.

Other treatment options
Anti-VEGF (anti-vascular endothelial growth factor) treatments block the formation of new abnormal blood vessels

No comments: